FR2024830B1 - - Google Patents

Info

Publication number
FR2024830B1
FR2024830B1 FR696938404A FR6938404A FR2024830B1 FR 2024830 B1 FR2024830 B1 FR 2024830B1 FR 696938404 A FR696938404 A FR 696938404A FR 6938404 A FR6938404 A FR 6938404A FR 2024830 B1 FR2024830 B1 FR 2024830B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR696938404A
Other languages
French (fr)
Other versions
FR2024830A1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of FR2024830A1 publication Critical patent/FR2024830A1/fr
Application granted granted Critical
Publication of FR2024830B1 publication Critical patent/FR2024830B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
FR696938404A 1968-11-12 1969-11-07 Expired FR2024830B1 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00775201A US3723432A (en) 1968-11-12 1968-11-12 1-substituted-4-aryl-2(1h)-quinazolinones and their preparation

Publications (2)

Publication Number Publication Date
FR2024830A1 FR2024830A1 (enExample) 1970-09-04
FR2024830B1 true FR2024830B1 (enExample) 1973-07-13

Family

ID=25103642

Family Applications (1)

Application Number Title Priority Date Filing Date
FR696938404A Expired FR2024830B1 (enExample) 1968-11-12 1969-11-07

Country Status (19)

Country Link
US (2) US3723432A (enExample)
AT (4) AT310169B (enExample)
BE (1) BE741529A (enExample)
BG (10) BG16042A3 (enExample)
BR (1) BR6914095D0 (enExample)
CH (1) CH521972A (enExample)
DE (1) DE1956384C3 (enExample)
DK (1) DK129347B (enExample)
ES (1) ES373377A1 (enExample)
FR (1) FR2024830B1 (enExample)
GB (1) GB1282612A (enExample)
IE (1) IE33933B1 (enExample)
IL (1) IL33348A (enExample)
NL (1) NL6916514A (enExample)
NO (1) NO124032B (enExample)
OA (1) OA03829A (enExample)
PL (1) PL72695B1 (enExample)
SE (2) SE374920B (enExample)
ZA (1) ZA697910B (enExample)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3923803A (en) * 1968-07-18 1975-12-02 Sumitomo Chemical Co 2(1H)-Quinozalinones and process therefor
US3642791A (en) * 1969-08-13 1972-02-15 Sandoz Ag Morpholino-1-substituted-2(1h)-quinazolinones
US4208343A (en) * 1970-10-30 1980-06-17 Westinghouse Electric Corp. 2,4 Diamino benzonitrile
BE785937A (fr) * 1971-07-08 1973-01-08 Sandoz Sa Nouveaux derives de la quinazoline, leur preparation et leur application comme medicaments
US3937705A (en) * 1972-03-09 1976-02-10 Sandoz, Inc. 1-isopropyl-7-methyl-4-(p-fluorophenyl)-2(1h)-quinazolinone
US4064246A (en) * 1976-10-12 1977-12-20 Sandoz, Inc. Hydroxymethyl-substituted-2(1H)-quinazolinones
US4071516A (en) * 1976-08-20 1978-01-31 Sandoz, Inc. 4-(Acyloxyphenyl)-quinazolin-2(1H)-ones
US4160092A (en) * 1977-06-16 1979-07-03 E. I. Du Pont De Nemours And Company Quinazolinone oxides and their use as intermediates for pharmaceutical agents
US4224328A (en) * 1979-04-11 1980-09-23 Sandoz, Inc. Methods with 1-substituted-4-aryl-quinazolin-2(1H)-ones and thiones and pyrido[2,3-d]pyrimidin-2-ones as platelet aggregation inhibitors
CH645362A5 (de) * 1979-07-05 1984-09-28 Sandoz Ag Verfahren zur herstellung von 4-phenyl-2(1h)-chinazolinonen.
FR2676042B1 (fr) * 1991-05-02 1993-07-23 Commissariat Energie Atomique Procede de preparation d'un borohydrure de metal alcalin tel que le borohydrure de lithium.
US7230000B1 (en) 1999-10-27 2007-06-12 Cytokinetics, Incorporated Methods and compositions utilizing quinazolinones
US6545004B1 (en) 1999-10-27 2003-04-08 Cytokinetics, Inc. Methods and compositions utilizing quinazolinones
AR038658A1 (es) * 2001-06-15 2005-01-26 Novartis Ag Derivados de 4-aril-2(1h) quinazolinona y 4-aril-quinazolina 2-sustituidas, un proceso para su preparacion, composiciones farmaceuticas y el uso de dichos derivados para la preparacion de un medicamento
WO2003043995A1 (en) * 2001-11-20 2003-05-30 Cytokinetics, Inc. Process for the racemization of chiral quinazolinones
US7009049B2 (en) * 2002-02-15 2006-03-07 Cytokinetics, Inc. Syntheses of quinazolinones
US7166595B2 (en) * 2002-05-09 2007-01-23 Cytokinetics, Inc. Compounds, methods and compositions
US7214800B2 (en) * 2002-05-09 2007-05-08 Cytokinetics, Inc. Compounds, compositions, and methods
US7038048B2 (en) * 2002-05-23 2006-05-02 Cytokinetics, Inc. 3H-pyridopyrimidin-4-one compounds, compositions, and methods of their use
US7041676B2 (en) * 2002-06-14 2006-05-09 Cytokinetics, Inc. Compounds, compositions, and methods
JP2006501201A (ja) * 2002-07-23 2006-01-12 サイトキネティクス・インコーポレーテッド 化合物、組成物および方法
EP1539180A4 (en) * 2002-08-21 2006-08-30 Cytokinetics Inc COMPOUNDS, COMPOSITIONS AND METHODS
EP1558083A4 (en) * 2002-09-30 2008-04-16 Cytokinetics Inc COMPOUNDS, COMPOSITIONS AND METHODS
GB0230015D0 (en) * 2002-12-23 2003-01-29 Novartis Ag Organic compounds
US7439241B2 (en) 2003-05-27 2008-10-21 Galderma Laboratories, Inc. Compounds, formulations, and methods for treating or preventing rosacea
US8410102B2 (en) 2003-05-27 2013-04-02 Galderma Laboratories Inc. Methods and compositions for treating or preventing erythema
EP1682534A2 (en) * 2003-11-03 2006-07-26 Cytokinetics, Inc. Pyrimidin-4-one compounds, compositions, and methods
EP1680420A4 (en) * 2003-11-07 2008-09-24 Cytokinetics Inc COMPOUNDS, COMPOSITIONS AND METHODS
EP1692112A4 (en) * 2003-12-08 2008-09-24 Cytokinetics Inc COMPOUNDS, COMPOSITIONS, AND METHODS
US8232285B2 (en) * 2007-06-22 2012-07-31 Arqule, Inc. Quinazolinone compounds and methods of use thereof
US8058469B2 (en) * 2008-11-03 2011-11-15 Sabic Innovative Plastics Ip B.V. Method for making carbamates, ureas and isocyanates
EP2329849B1 (en) 2009-11-18 2015-04-29 Galderma Research & Development Combination of alpha-2 adrenergic receptor agonist and non-steroidal anti-inflammatory agent for treating or preventing an inflammatory skin disorder
US8394800B2 (en) * 2009-11-19 2013-03-12 Galderma Laboratories, L.P. Method for treating psoriasis
RU2535008C2 (ru) 2010-03-26 2014-12-10 Галдерма Ресерч Энд Девелопмент Улучшенные способы и композиции для безопасного и эффективного лечения телеангиэктазии
MX2012010824A (es) 2010-03-26 2012-10-10 Galderma Res & Dev Metodos y composiciones mejoradas para tratamiento seguro y efectivo del eritema.
US8053427B1 (en) 2010-10-21 2011-11-08 Galderma R&D SNC Brimonidine gel composition
SG189896A1 (en) 2010-10-21 2013-06-28 Galderma Sa Brimonidine gel compositions and methods of use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3452041A (en) * 1965-05-19 1969-06-24 American Home Prod Hydantoin compounds and methods of preparation

Also Published As

Publication number Publication date
BG16188A3 (bg) 1972-07-20
BG16043A3 (bg) 1972-05-20
DK129347B (da) 1974-09-30
IL33348A0 (en) 1970-01-29
BE741529A (enExample) 1970-05-11
BG16039A3 (bg) 1972-05-20
BG16037A3 (bg) 1972-05-20
BG16040A3 (bg) 1972-05-20
AT319949B (de) 1975-01-10
DE1956384C3 (de) 1980-10-09
BG16041A3 (bg) 1972-05-20
ES373377A1 (es) 1972-05-16
CH521972A (de) 1972-04-30
GB1282612A (en) 1972-07-19
PL72695B1 (en) 1974-08-30
OA03829A (fr) 1971-12-24
NL6916514A (enExample) 1970-05-14
BG16038A3 (bg) 1972-05-20
SE376917B (enExample) 1975-06-16
AT310169B (de) 1973-09-25
US3925548A (en) 1975-12-09
FR2024830A1 (enExample) 1970-09-04
IE33933B1 (en) 1974-12-11
SU366612A3 (enExample) 1973-01-16
BG16042A3 (bg) 1972-05-20
BR6914095D0 (pt) 1973-02-13
BG15573A3 (bg) 1976-06-26
DK129347C (enExample) 1975-02-17
US3723432A (en) 1973-03-27
ZA697910B (en) 1971-07-28
IL33348A (en) 1973-04-30
IE33933L (en) 1970-05-12
NO124032B (enExample) 1972-02-21
DE1956384B2 (de) 1980-02-07
AT319950B (de) 1975-01-10
DE1956384A1 (de) 1970-06-11
USB313531I5 (enExample) 1975-01-28
BG16036A3 (bg) 1972-05-20
AT310176B (de) 1973-09-25
SE374920B (enExample) 1975-03-24

Similar Documents

Publication Publication Date Title
DK129347C (enExample)
AU1946070A (enExample)
AU428130B2 (enExample)
AU2374870A (enExample)
AU5184069A (enExample)
AU6168869A (enExample)
AU6171569A (enExample)
AU416157B2 (enExample)
AU429879B2 (enExample)
AU2581067A (enExample)
AU4811568A (enExample)
AU421558B1 (enExample)
AU4744468A (enExample)
AU2580267A (enExample)
AU3224368A (enExample)
AU3789668A (enExample)
BE581157A (enExample)
BE708888A (enExample)
AU463027A (enExample)
AU4503667A (enExample)
AU479393A (enExample)
BE709274A (enExample)
AU4464266A (enExample)
AU4224469A (enExample)
AU3083868A (enExample)

Legal Events

Date Code Title Description
ST Notification of lapse